drugset / Trial / NCT07052136

Efficacy Comparison Between Levetiracetam and Valproic Acid in Pediatric Patients With Status Epilepticus

NCT07052136

Completed 138 enrolled RESnTEC, Institute of Research
RandomizedParallel-groupOpen-labelTreatment

Summary

Since there is a significant degree of variability in the results of previous studies and there exists a thirst for local data regarding this topic, the current study was planned, with the objective of comparing the efficacy of levetiracetam versus valproic acid in pediatric patients with status epilepticus.

Timeline

Start
2024-11-01
Primary completion
2025-04-30
Completion
2025-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Levetiracetam Other / unclassified 30 mg/kg Intravenous
Subject Valproic Acid Small molecule 10 mg/kg Intravenous

Indications

No indication recorded.